OncoMasTR test to launch in 2018 and will reduce the number of patients receiving unnecessary chemotherapy
OncoMark, a University College Dublin (UCD) spin-out company, today announced that is has secured €2.1 million in funding.
Last year, 250 investors listened to pitches from 202 start-ups that HBAN identified as investor-ready
50 of those 202 start-ups – almost 25% – were successful in finding their investor match. Relationships between investees and angel investors typically last 4 to 7 years
With the new year comes new opportunities.